Healthtech Startups
16,921 companies tagged Healthtech, with their investors and founders.
Perfuze develops medical devices for the treatment of acute ischemic stroke, focused on addressing unmet clinical needs in mechanical thrombectomy. The company is a medical technology firm based in Ireland with clinical partnerships in the US and Europe.
2 investors
PerioTrap develops a microbiome-friendly toothpaste that selectively targets harmful oral bacteria while preserving beneficial bacteria, using patented PerioTrap® technology designed to reduce gum inflammation risk. The company manufactures products in Germany for consumers seeking targeted gum health support.
2 investors
PeriVision develops the VisionOne platform, combining AI, virtual reality, and cloud technology to test and understand visual function for eye conditions such as glaucoma. Its systems target ophthalmology practices and hospitals, aiming to improve testing workflows and provide deeper clinical insight into eye diseases.
2 investors
Perosphere is a medical technology company developing point-of-care coagulation diagnostics, including a pharmacodynamic test that provides a global view of a patient's coagulation status. Its lead product is CE Marked in the European Union but not FDA cleared in the United States.
2 investors
PFx Biotech develops alternative protein products aimed at meeting high nutritional standards and offering health-promoting properties. The company operates in the alternative protein and biotech space.
2 investors
Pharaoh Neuro is a neurotechnology company focused on protecting and restoring brain health, with an emphasis on the fluids surrounding the brain such as cerebrospinal fluid. It develops devices and technology in the neurology and brain health category.
2 investors
PharmAbcine is a biotech company developing therapeutic antibodies, with a focus on immuno-oncology and antibody-based cancer treatments.
2 investors
PBR Life Sciences provides AI-powered analytics and market intelligence for healthcare organizations operating in emerging markets, particularly in Sub-Saharan Africa. The company delivers data-as-a-service insights to pharmaceutical companies, NGOs, and life sciences organizations.
2 investors
PharmaJet develops needle-free injection systems for delivering vaccines and therapeutics, used across a range of therapeutic areas including infectious disease prevention and cancer treatment. Its reusable devices serve pharmaceutical partners and healthcare providers as an alternative to traditional needle-based delivery.
2 investors
PharOS develops and markets generic and value-added pharmaceutical products for distribution to more than 115 countries. The company employs scientists, biologists, chemists, and pharmacists focused on drug development with emphasis on customer service and product lifecycle extension.
2 investors
Phase Genomics develops long-range genome sequencing technology based on proximity ligation, along with computational tools, for scientists studying cancer, inherited diseases, microbiomes, and biodiversity. It serves academic and research institutions and biopharmaceutical firms across life sciences, medicine, and agriculture.
2 investors
Phase Zero builds an AI copilot for clinical registry teams that extracts and abstracts data points from clinical documentation such as EMS run sheets and pathology reports, helping registrars find cases and complete abstractions. It also matches cases to clinical guidelines, detects treatment variances, and flags improvement opportunities for quality and compliance workflows.
2 investors
PhaseBio is a company focused on developing treatments for cardiovascular disease, which is a leading cause of death in the United States.
2 investors
Pheast Therapeutics develops immunotherapies targeting cancer, building on foundational research from Stanford's stem cell research institute. The company focuses on translating scientific discoveries into clinical therapies for patients.
2 investors
Pheon Therapeutics develops targeted oncology treatments, focusing on antibody-drug conjugates (ADCs) for cancer therapy.
2 investors
Philduct is a Japanese oral-tech company that develops DPEARL, a 3D-printed clear aligner orthodontic service, along with remote dental consultation and digital dentistry services. It operates a dental technology R&D lab and targets consumers seeking affordable preventive oral healthcare in Japan.
2 investors
Phlox Therapeutics develops RNA-based precision genetic medicines and gene therapies to treat and potentially cure rare genetic heart diseases such as cardiomyopathies and laminopathies. The company targets the underlying causes of genetic cardiac dysfunction for patients underserved by current standard of care.
2 investors
Phoebe is an applied AI company based in New York City that works to bring AI into real-world applications.
2 investors
Phrase Health provides analytics tools for health systems to reduce unwarranted clinical variation within the electronic health record (EHR), aiming to lower costs and improve patient outcomes. Spun out of Children's Hospital of Philadelphia, its software applies quality improvement methods to clinical decision support and EHR governance for hospitals and health systems.
2 investors
Digital Medical Scribe is an educational content platform providing articles, industry news, expert interviews, and tutorials about digital medical scribing technologies and practices in the United States healthcare sector.
2 investors
symplr Directory centralizes and governs provider data across healthcare organizations, helping health plans and health systems maintain accurate, compliant provider information for credentialing, claims, and member-facing systems. The platform integrates with EHRs, payer systems, and other healthcare tools to eliminate data silos and automate compliance with regulatory requirements including CMS, NCQA, HIPAA, and the No Surprises Act.
2 investors
Pi Health develops software and AI tools to make clinical research more inclusive, efficient, and globally scalable by eliminating barriers in clinical trial recruitment and execution for pharmaceutical and biotech companies.
2 investors
LuminDx provides virtual dermatology care for hair, skin, and nail conditions through a digital-first delivery model.
2 investors
Pillar Biosciences develops kitted next-generation sequencing (NGS) panels and its SLIMamp single-tube library preparation technology for clinical and research laboratories, focused on cancer diagnostics. Its oncoReveal portfolio of RUO and IVD oncology panels covers solid tumors, hematologic cancers, and liquid biopsy, aiming to deliver faster, lower-cost genomic testing for precision medicine.
2 investors